Belgian pharmaceutical company Ceres Pharma NV has acquired 100 percent of the shares of BioCo Kft., a leading Hungarian developer, manufacturer, and distributor of dietary supplements, subject to regulatory approval.
BioCo, a family-owned business, markets its products under the BioCo® brand, the third-largest dietary supplement brand in Hungarian pharmacies. BioCo products are available in over 90 percent of pharmacies, as well as in major drugstore chains dm and Rossmann, and in leading health food store networks. The company reported 8.5 million euros in revenue in 2024.
Ceres Pharma CEO Mario Debel said the acquisition aligns perfectly with the company’s growth strategy: “BioCo will strengthen our position in Hungary, especially in pharmacies. The brands and distribution channels of BioCo and Ceres Pharma Hungary complement each other very well. We also plan to market BioCo products in other countries and produce some of our products in BioCo’s GMP-certified facility.”
Nikolett Urbán, owner and Managing Director of BioCo, added: “We are delighted to join Ceres Pharma, a strong, dynamic, and fast-growing international group. Together, we can accelerate our ambitious growth plans in Hungary and beyond.”
Urbán and co-Managing Director Judit Szép will continue to lead BioCo and drive innovation within Ceres Pharma Hungary. The purchase price was not disclosed.
Ceres Pharma, founded in 2017 by Mario Debel and Alychlo, and acquired in 2021 by the French Naxicap Partners, a private equity firm active in pharmaceuticals, medical devices, biocides, cosmetics, dietary supplements, and compounding across Belgium, Italy, and Central and Eastern Europe.
